1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral T cell repertoire evolution in resectable NSCLC treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; Caushi, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Guo, H.; Merghoub, T.; Chaft, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase 1 study of NY-ESO-1 vaccine + ipilimumab (ipi) in patients with unresectable or metastatic melanoma
    Meeting Abstract

    Slingluff, C.; Zarour, H.; Postow, M.; Friedlander, P.; Devoe, C.; Mauldin, I.; Smith, K.; Macri, M.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab in checkpoint inhibitor refractory advanced or unresectable melanoma
    Meeting Abstract

    Shoushtari, A.; Olszanski, A.; Hornyak, T.; Wolchok, J.; Vetrhus, S.; Handeland, K. R.; Kuryk, L.; Jaderberg, M.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Cytokine release syndrome (CRS) following treatment with tebentafusp, a novel bispecific TCR-anti-CD3 directed against gp100, in patients with advanced melanoma
    Meeting Abstract

    Shoushtari, A.; Middleton, M.; Stevens, N.; Evans, T.; Infante, J.; Sznol, M.; Anthoney, A.; Gupta, A.; Woodcock, V.; Wiseman, T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Laminar Wash™ AUTO system: A reliable walk-away sample preparation solution for better TIL recovery without centrifugation
    Meeting Abstract

    Kim, I.; Lye, M.; Zappasodi, R.; Schulze, I.; Eberle, C.; Ke, C. Y.; Cheng, K. L.; Kon, I. C.; Pek, R.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • 5-year survival outcomes of the CheckMate 067 phase III trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma
    Meeting Abstract

    Larkin, J. M. G.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Imaging patients with metastatic castration-resistant prostate cancer using (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody
    Journal Article

    Carrasquillo, J. A.; Fine, B. M.; Pandit-Taskar, N.; Larson, S. M.; Fleming, S. E.; Fox, J. J.; Cheal, S. M.; O'Donoghue, J. A.; Ruan, S.; Ragupathi, G.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save